Canadian Respiratory Journal (Jan 2004)
The Canadian Optimal Therapy of COPD Trial: Design, Organization and Patient Recruitment
Abstract
BACKGROUND: There are no published studies that have assessed whether adding long-acting beta 2-agonist bronchodilators and/or inhaled steroids to chronic therapy with tiotropium would provide additional clinical benefit to patients with moderate to severe chronic obstructive pulmonary disease (COPD).